New Drug Approvals for 2020
This activity is supported by
MJH Life Sciences, the parent company of Pharmacy Times® and PTCE.
MJH Life Sciences, the parent company of Pharmacy Times® and PTCE.
Faculty
Mary Barna Bridgeman, PharmD, BCPS, BCGP
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Clinical Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey
Patrick J. Bridgeman, Jr., PharmD, BCPS
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Emergency Medicine Clinical Pharmacist
Robert Wood Johnson University Hospital
New Brunswick, New Jersey
Program Description
Every year, the Food and Drug Administration (FDA) approves a wide range of new drugs and biological products, some that have never been used in clinical practice before. Pharmacists play a vital role on the health care team by being medication experts on these new medications and treatment alternatives and can assist with providing patients with the best care possible. Pharmacy technicians also play an important role in ensuring patients are equipped with the information they need to ensure the safe and effective use of these agents. Innovation has led to the FDA approval of 53 novel drugs in 2020. This activity will provide a complete table including a list of these medications as well as a brief primer on their indication so that individuals are able to familiarize themselves with these new medications. In addition, the activity will delve deeper into select medications to highlight important characteristics such as mechanism of action, dosing, administration, safety, and efficacy. It is vital that pharmacists and pharmacy technicians stay abreast of the unique nuances of new medications so that they can continue to optimize the care of their patients. This is especially important during the infodemic caused by COVID-19 where patients and other health care providers may seek the most up-to-date information from the pharmacy team.
Target audience: Pharmacy technicians
Type of activity: Knowledge
Release date: January 29, 2021
Expiration date: January 29, 2022
Time to complete activity: 3.0 hours
Fee: Free
Educational Objectives for Pharmacy Technicians:
At the completion of this activity, participants will be able to:
- Associate the names of the new drugs approved by the U.S. Food and Drug Administration in 2020 with the diseases or conditions they are indicated for
- Recognize characteristics of select newly approved drugs such as route of administration and important safety information
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 3.0 contact hours (0.30 CEU) under the ACPE universal activity number 0290-0000-21-029-H01-T. The activity is available for CE credit through January 29, 2022.Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, read the article in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
Faculty
Mary Barna Bridgeman, PharmD, BCPS, BCGP, has the following financial relationship with a commercial interest to disclose:
Speakers Bureau: AstraZeneca
Patrick J. Bridgeman, Jr., PharmD, BCPS, has the following financial relationship with a commercial interest to disclose:
Spouse: Speakers Bureau: AstraZeneca
The following contributors have no relevant financial relationships with commercial interests to disclose:
Pharmacy Times Continuing Education™ Planning Staff— Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Dipti Desai, PharmD, CHCP; Liza Patel, PharmD, RPh; Kelly McCormick; Susan Pordon; and Brianna Winters
Anonymous peer reviewers were part of the content validation and conflict resolution and have no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms
